The distribution of antibiotic use and its association with antibiotic resistance

Antibiotic use is a primary driver of antibiotic resistance. However, antibiotic use can be distributed in different ways in a population, and the association between the distribution of use and antibiotic resistance has not been explored. Here we tested the hypothesis that repeated use of antibiotics has a stronger association with population-wide antibiotic resistance than broadly- distributed, low-intensity use. First, we characterized the distribution of outpatient antibiotic use across US states, finding that antibiotic use is uneven and that repeated use of antibiotics makes up a minority of antibiotic use. Second, we compared antibiotic use with resistance for 72 pathogen-antibiotic combinations across states. Finally, having partitioned total use into extensive and intensive margins, we found that intense use had a weaker association with resistance than extensive use. If the use-resistance relationship is causal, these results suggest that reducing total use and selection intensity will require reducing broadly-distributed, low- intensity use.

[1]  M. Lipsitch,et al.  The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coli. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Holmes,et al.  Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study , 2018, BMC Medicine.

[3]  Michael Lawrence Barnett,et al.  Trends in outpatient antibiotic use and prescribing practice among US older adults, 2011-15: observational study , 2018, BMJ.

[4]  M. Lipsitch,et al.  Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora , 2018, Proceedings of the National Academy of Sciences.

[5]  Candida Geerdens,et al.  Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens , 2018, Antimicrobial Resistance & Infection Control.

[6]  T. Smieszek,et al.  Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association , 2018, The Journal of antimicrobial chemotherapy.

[7]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[8]  Sarah F. McGough,et al.  Antibiotic Resistance Increases with Local Temperature , 2017, Nature Climate Change.

[9]  Y. Grad,et al.  Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014 , 2017, Journal of Clinical Microbiology.

[10]  J. Brownstein,et al.  Evaluating the Relationship Between Hospital Antibiotic Use and Antibiotic Resistance in Common Nosocomial Pathogens , 2017, Infection Control & Hospital Epidemiology.

[11]  Chantal Quinten,et al.  ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals , 2017, EFSA journal. European Food Safety Authority.

[12]  I. Petersen,et al.  Antibiotic prescribing frequency amongst patients in primary care: a cohort study using electronic health records , 2017, The Journal of antimicrobial chemotherapy.

[13]  T. Korman,et al.  Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network , 2017, Annals of Clinical Microbiology and Antimicrobials.

[14]  Enrique F Schisterman,et al.  Collinearity and Causal Diagrams: A Lesson on the Importance of Model Specification , 2017, Epidemiology.

[15]  S. Aitken,et al.  Regional variation in antibiotic prescribing among medicare part D enrollees, 2013 , 2016, BMC Infectious Diseases.

[16]  I. Bogoch,et al.  A Platform for Monitoring Regional Antimicrobial Resistance, Using Online Data Sources: ResistanceOpen. , 2016, The Journal of infectious diseases.

[17]  A. Suskind,et al.  Incidence and Management of Uncomplicated Recurrent Urinary Tract Infections in a National Sample of Women in the United States. , 2016, Urology.

[18]  K. Owusu-Edusei,et al.  Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000-2010. , 2015, American journal of preventive medicine.

[19]  S. Schrag,et al.  US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  H. Goossens,et al.  Exploring the association between resistance and outpatient antibiotic use expressed as DDDs or packages. , 2015, The Journal of antimicrobial chemotherapy.

[21]  Bryan T Grenfell,et al.  Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. , 2014, The Lancet. Infectious diseases.

[22]  Herman Goossens,et al.  A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance , 2014, BMC Infectious Diseases.

[23]  Matthias Cavassini,et al.  [Infectious diseases]. , 2014, Revue medicale suisse.

[24]  R. Guy,et al.  English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) Report 2014 , 2014 .

[25]  R. Hunkler,et al.  More on U.S. outpatient antibiotic prescribing, 2010. , 2013, The New England journal of medicine.

[26]  R. Hunkler,et al.  U.S. outpatient antibiotic prescribing, 2010. , 2013, The New England journal of medicine.

[27]  Y. Carmeli,et al.  Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance , 2013, Clinical Microbiology Reviews.

[28]  Yuting Zhang,et al.  Geographic variation in outpatient antibiotic prescribing among older adults. , 2012, Archives of internal medicine.

[29]  M. Samore,et al.  Outpatient antibiotic use in the United States: time to "get smarter". , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  M. Haber,et al.  Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  D. Osmon,et al.  Antimicrobial prophylaxis in adults. , 2011, Mayo Clinic proceedings.

[32]  Alastair D Hay,et al.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[33]  A. Berrington Antimicrobial prescribing in hospitals: be careful what you measure. , 2010, The Journal of antimicrobial chemotherapy.

[34]  Marc Lipsitch,et al.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? , 2009, Journal of The Royal Society Interface.

[35]  H. Goossens,et al.  Antimicrobial Drug Use and Resistance in Europe , 2008, Emerging infectious diseases.

[36]  F. Dunstan,et al.  Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. , 2007, The Journal of antimicrobial chemotherapy.

[37]  John Stelling,et al.  Medical Microbiology: Analysis and Presentation of Cumulative Antibiograms: A New Consensus Guideline from the Clinical and Laboratory Standards Institute , 2007 .

[38]  B. McMahon,et al.  The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  M. Edmond,et al.  Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  Matthew H. Samore,et al.  Antimicrobial Resistance Determinants and Future Control , 2005, Emerging infectious diseases.

[41]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[42]  J. Turnidge,et al.  Antibiotic use and resistance—proving the obvious , 2005, The Lancet.

[43]  Y. Carmeli,et al.  Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients , 2003, Emerging infectious diseases.

[44]  B. McMahon,et al.  The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections , 2003, Annals of Internal Medicine.

[45]  J. García-Rodríguez,et al.  Dynamics of nasopharyngeal colonization by potential respiratory pathogens. , 2002, The Journal of antimicrobial chemotherapy.

[46]  Tetsuya Matsumoto,et al.  Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate. , 2002, The Journal of antimicrobial chemotherapy.

[47]  B. Schwartz,et al.  Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  M. Lipsitch,et al.  Antimicrobial Use and Antimicrobial Resistance: A Population Perspective , 2002, Emerging Infectious Diseases.

[49]  O. Cars,et al.  The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe , 2002, Emerging Infectious Diseases.

[50]  P. Collignon,et al.  Effect of βlactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study , 2002, BMJ : British Medical Journal.

[51]  F. Baquero,et al.  Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae , 2002, Journal of Clinical Microbiology.

[52]  O. Cars,et al.  A European study on the relationship between antimicrobial use and antimicrobial resistance. , 2002, Emerging infectious diseases.

[53]  C. Mcnulty,et al.  Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. , 2001, BMJ : British Medical Journal.

[54]  Y. Carmeli,et al.  Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  M. Lipsitch,et al.  The rise and fall of antimicrobial resistance. , 2001, Trends in microbiology.

[56]  D. Livermore,et al.  Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. , 2000, The Journal of antimicrobial chemotherapy.

[57]  T. Popović,et al.  Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  F. Dunstan,et al.  Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8 , 1999, BMJ.

[59]  I. Gould A review of the role of antibiotic policies in the control of antibiotic resistance. , 1999, The Journal of antimicrobial chemotherapy.

[60]  A V Prochazka,et al.  The assessment of refill compliance using pharmacy records: methods, validity, and applications. , 1997, Journal of clinical epidemiology.

[61]  F. M. Stewart,et al.  The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  G. Stefánsdóttir,et al.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.

[63]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .